Clinical Trial Update: Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy [NA]

View source ↗

Summary

This document summarizes the results of a completed clinical trial evaluating the effect of rituximab therapy on cardiovascular risk markers in patients with rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Endothelial Function, Rheumatoid Arthritis | NA | Status: COMPLETED | Results posted: 2014-06-23